IN2014DN08526A - - Google Patents
Info
- Publication number
- IN2014DN08526A IN2014DN08526A IN8526DEN2014A IN2014DN08526A IN 2014DN08526 A IN2014DN08526 A IN 2014DN08526A IN 8526DEN2014 A IN8526DEN2014 A IN 8526DEN2014A IN 2014DN08526 A IN2014DN08526 A IN 2014DN08526A
- Authority
- IN
- India
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/49—Mixing systems, i.e. flow charts or diagrams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/80—Mixing plants; Combinations of mixers
- B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
- B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/20—Measuring; Control or regulation
- B01F35/21—Measuring
- B01F35/2132—Concentration, pH, pOH, p(ION) or oxygen-demand
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/715—Feeding the components in several steps, e.g. successive steps
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10061—Methods of inactivation or attenuation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261666145P | 2012-06-29 | 2012-06-29 | |
PCT/US2013/045677 WO2014004103A1 (en) | 2012-06-29 | 2013-06-13 | Methods for inactivating viruses during a protein purification process |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN08526A true IN2014DN08526A (ja) | 2015-05-15 |
Family
ID=49783749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN8526DEN2014 IN2014DN08526A (ja) | 2012-06-29 | 2014-10-13 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9809799B2 (ja) |
EP (2) | EP3981873A1 (ja) |
JP (2) | JP6182210B2 (ja) |
CN (2) | CN107188926B (ja) |
ES (1) | ES2895173T3 (ja) |
IN (1) | IN2014DN08526A (ja) |
SG (1) | SG11201406407TA (ja) |
WO (1) | WO2014004103A1 (ja) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
MX2015012114A (es) * | 2013-03-08 | 2016-01-12 | Genzyme Corp | Fabricacion continua integrada de principios activos proteinicos terapeuticos. |
TWI709570B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析法及製法 |
TWI709569B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析樹脂及其用於製造方法的用途 |
US10435670B2 (en) | 2014-04-15 | 2019-10-08 | Boehringer Ingelheim International Gmbh | Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product |
JP6521351B2 (ja) * | 2014-10-14 | 2019-05-29 | テックプロジェクトサービス株式会社 | ウィルス不活化およびサンプリング装置 |
EP3277397A1 (en) * | 2015-03-31 | 2018-02-07 | GE Healthcare Bio-Sciences AB | A liquid chromatograhy system, a device, and a method |
WO2016207328A1 (en) * | 2015-06-24 | 2016-12-29 | Glycotope Gmbh | PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES |
JP7032046B2 (ja) * | 2016-01-22 | 2022-03-08 | 旭化成メディカル株式会社 | 生理活性物質の連続的な定流速精製方法 |
EP3426683A1 (en) * | 2016-03-11 | 2019-01-16 | Boehringer Ingelheim International GmbH | Methods for continuously inactivating a virus during manufacture of a protein |
CN105841984A (zh) * | 2016-03-18 | 2016-08-10 | 中国石油天然气股份有限公司 | 聚合物配注工艺设备检测评价装置 |
US11155794B2 (en) * | 2016-08-23 | 2021-10-26 | Alexion Pharmaceuticals, Inc. | Method of purifying a heterologous protein from an egg white |
US11547957B2 (en) | 2017-05-11 | 2023-01-10 | Emd Millipore Corporation | Method of maintaining narrow residence time distributions in continuous flow systems |
WO2018208447A1 (en) * | 2017-05-11 | 2018-11-15 | Emd Millipore Corporation | Mechanical method of maintaining narrow residence time distributions in continuous flow systems |
JP6596043B2 (ja) | 2017-07-31 | 2019-10-23 | 株式会社Subaru | 車両の走行制御システム |
GB201802593D0 (en) * | 2018-02-16 | 2018-04-04 | Fujifilm Diosynth Biotechnologies Uk Ltd | Rig |
JP2021536353A (ja) | 2018-08-31 | 2021-12-27 | ジェンザイム・コーポレーション | 無菌クロマトグラフィー樹脂および製造方法におけるその使用 |
SG11202103790WA (en) * | 2018-11-15 | 2021-05-28 | Bayer Healthcare Llc | Viral inactivation methods for continuous manufacturing of antibodies |
WO2020117760A1 (en) * | 2018-12-03 | 2020-06-11 | Duke University | Purification method for recombinant proteins and nanoparticles |
KR20210118815A (ko) * | 2019-01-23 | 2021-10-01 | 다이이찌 산쿄 가부시키가이샤 | 활성탄 재료를 사용하는 공정을 포함하는 항체 정제 방법 |
KR20210009982A (ko) * | 2019-07-18 | 2021-01-27 | 에이비온 주식회사 | 2당화된 인터페론-베타 단백질의 정제 방법 |
FR3099066B1 (fr) * | 2019-07-26 | 2021-08-13 | Novasep Process | Procédé de purification d’une substance cible avec inactivation virale |
WO2021197249A1 (zh) * | 2020-03-30 | 2021-10-07 | 上海复宏汉霖生物技术股份有限公司 | 一种用于靶分子连续纯化的系统和方法 |
JP2023531407A (ja) | 2020-06-16 | 2023-07-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 押出し流れ反応器内部に均一の供給流を与える方法 |
TW202323817A (zh) * | 2021-10-07 | 2023-06-16 | 美商再生元醫藥公司 | Ph建模及控制之系統及方法 |
EP4357009A1 (de) | 2022-10-17 | 2024-04-24 | Sartorius Stedim Biotech GmbH | Verfahren und anordnung zum betrieb eines kontinuierlichen downstream-prozesses |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4639513A (en) * | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
EP0629135B1 (en) | 1992-03-02 | 2000-07-26 | Bioeng, Inc. | Viral inactivation method |
JPH09500015A (ja) | 1993-06-23 | 1997-01-07 | ニューヨーク ブラッド センター,インコーポレイティド | 血液のウィルス不活性化のためのシステム |
WO1996015231A2 (en) | 1994-11-10 | 1996-05-23 | Immuno Aktiengesellschaft | Method for producing biologicals in protein-free culture |
US6686191B1 (en) | 1995-09-22 | 2004-02-03 | Bayer Healthcare Llc | Preparation of virally inactivated intravenously injectable immune serum globulin |
GB9611698D0 (en) | 1996-06-05 | 1996-08-07 | Iatros Ltd | Fluid processing |
WO1998044942A1 (de) * | 1997-04-08 | 1998-10-15 | Baxter Aktiengesellschaft | Immuntolerante prothrombinkomplex-präparation |
US5886154A (en) | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
DE19923027C2 (de) * | 1999-05-19 | 2002-09-19 | Aventis Behring Gmbh | Verfahren zur Inaktivierung von Viren |
WO2002092806A1 (en) | 2001-05-15 | 2002-11-21 | V.I. Technologies, Inc. | Apparatus for the inactivation of pathogens in protein-containingfluids |
EP1415669A1 (en) | 2002-09-19 | 2004-05-06 | Aventis Behring GmbH | Process for sterilization of protein containing biological compositions |
AU2003300951A1 (en) | 2002-12-20 | 2004-07-22 | Baxter International Inc. | Fluid treatment method, apparatus and system |
US20040256329A1 (en) | 2003-06-13 | 2004-12-23 | Peter Meserol | Photodynamic biological fluid pathogen inactivation/filtering apparatus and method |
US8271139B2 (en) | 2003-10-17 | 2012-09-18 | Asahi Kasei Bioprocess, Inc. | Multi-stage accurate blending system and method |
WO2005090403A2 (en) | 2004-03-12 | 2005-09-29 | Biovest International, Inc. | Method and apparatus for antibody purification |
CA2604877A1 (en) | 2005-04-11 | 2006-10-19 | J.P. Sercel Associates Inc. | Protein purification |
WO2009045897A1 (en) | 2007-10-03 | 2009-04-09 | Dyax Corp. | Systems and methods for purifying proteins |
CN103396480A (zh) * | 2008-05-15 | 2013-11-20 | 诺沃—诺迪斯克有限公司 | 抗体纯化方法 |
JP5808249B2 (ja) * | 2008-10-20 | 2015-11-10 | アッヴィ・インコーポレイテッド | プロテインaアフィニティークロマトグラフィーを用いる抗体の単離および精製 |
AU2009307737B2 (en) * | 2008-10-20 | 2015-07-23 | Abbvie Inc. | Viral inactivation during purification of antibodies |
SG195555A1 (en) | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
WO2011028753A1 (en) | 2009-09-01 | 2011-03-10 | Genentech, Inc. | Enhanced protein purification through a modified protein a elution |
US9527010B2 (en) * | 2009-09-25 | 2016-12-27 | Ge Healthcare Bio-Sciences Corp. | Separation system and method |
WO2012014183A1 (en) * | 2010-07-30 | 2012-02-02 | Pfizer Inc. | Tandem purification of proteins |
SG189872A1 (en) | 2010-10-11 | 2013-06-28 | Abbvie Inc | Processes for purification of proteins |
CN103562145B (zh) * | 2010-12-06 | 2016-09-21 | 颇尔公司 | 生物制品的连续加工方法 |
SG10201604559TA (en) | 2011-06-08 | 2016-07-28 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
KR102157227B1 (ko) * | 2011-07-08 | 2020-09-17 | 이엠디 밀리포어 코포레이션 | 일회용 생명공학적 공정용의 개선된 심층 필터 |
US9096648B2 (en) | 2011-08-19 | 2015-08-04 | Emd Millipore Corporation | Methods of reducing level of one or more impurities in a sample during protein purification |
CN102492040B (zh) * | 2011-12-29 | 2014-06-25 | 嘉和生物药业有限公司 | 一种抗her2或/和抗her3抗体蛋白的纯化方法 |
EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
MX2015012114A (es) * | 2013-03-08 | 2016-01-12 | Genzyme Corp | Fabricacion continua integrada de principios activos proteinicos terapeuticos. |
-
2013
- 2013-06-13 WO PCT/US2013/045677 patent/WO2014004103A1/en active Application Filing
- 2013-06-13 CN CN201710252174.0A patent/CN107188926B/zh active Active
- 2013-06-13 JP JP2015520259A patent/JP6182210B2/ja active Active
- 2013-06-13 EP EP21191783.6A patent/EP3981873A1/en active Pending
- 2013-06-13 ES ES13810248T patent/ES2895173T3/es active Active
- 2013-06-13 EP EP13810248.8A patent/EP2867359B1/en active Active
- 2013-06-13 US US14/390,924 patent/US9809799B2/en active Active
- 2013-06-13 CN CN201380034780.5A patent/CN104411820B/zh active Active
- 2013-06-13 SG SG11201406407TA patent/SG11201406407TA/en unknown
-
2014
- 2014-10-13 IN IN8526DEN2014 patent/IN2014DN08526A/en unknown
-
2017
- 2017-03-22 JP JP2017055363A patent/JP6457575B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP6182210B2 (ja) | 2017-08-16 |
EP2867359A4 (en) | 2015-11-11 |
EP3981873A1 (en) | 2022-04-13 |
JP2017148051A (ja) | 2017-08-31 |
JP6457575B2 (ja) | 2019-01-23 |
CN107188926A (zh) | 2017-09-22 |
CN104411820B (zh) | 2017-05-03 |
CN104411820A (zh) | 2015-03-11 |
EP2867359B1 (en) | 2021-09-15 |
US9809799B2 (en) | 2017-11-07 |
CN107188926B (zh) | 2021-02-09 |
ES2895173T3 (es) | 2022-02-17 |
US20150064769A1 (en) | 2015-03-05 |
SG11201406407TA (en) | 2014-11-27 |
JP2015522017A (ja) | 2015-08-03 |
EP2867359A1 (en) | 2015-05-06 |
WO2014004103A1 (en) | 2014-01-03 |